Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
grade C 28.81 1.09% 0.31
CRY closed up 1.09 percent on Thursday, January 17, 2019, on 84 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CRY trend table...

Date Alert Name Type % Chg
Jan 17 Crossed Above 50 DMA Bullish 0.00%
Jan 17 Stochastic Reached Overbought Strength 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 17 Upper Bollinger Band Touch Strength 0.00%
Jan 16 50 DMA Resistance Bearish 1.09%
Jan 16 Gapped Up Strength 1.09%
Jan 16 Upper Bollinger Band Touch Strength 1.09%
Jan 15 Crossed Above 20 DMA Bullish 4.12%
Jan 14 Gapped Down Weakness 7.26%

Older signals for CRY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Is CRY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 36.05
52 Week Low 16.8
Average Volume 136,600
200-Day Moving Average 29.1473
50-Day Moving Average 28.6476
20-Day Moving Average 27.2915
10-Day Moving Average 27.573
Average True Range 0.9571
ADX 18.76
+DI 26.5688
-DI 22.9738
Chandelier Exit (Long, 3 ATRs ) 26.0687
Chandelier Exit (Short, 3 ATRs ) 28.4513
Upper Bollinger Band 28.8956
Lower Bollinger Band 25.6874
Percent B (%b) 0.97
BandWidth 11.755308
MACD Line -0.1669
MACD Signal Line -0.4321
MACD Histogram 0.2652
Fundamentals Value
Market Cap 963.58 Million
Num Shares 33.4 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 87.30
Price-to-Sales 3.65
Price-to-Book 3.05
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.70
Resistance 3 (R3) 29.64 29.29 29.55
Resistance 2 (R2) 29.29 29.06 29.32 29.50
Resistance 1 (R1) 29.05 28.93 29.17 29.11 29.45
Pivot Point 28.70 28.70 28.76 28.73 28.70
Support 1 (S1) 28.46 28.47 28.58 28.52 28.17
Support 2 (S2) 28.11 28.34 28.14 28.12
Support 3 (S3) 27.87 28.11 28.07
Support 4 (S4) 27.93